Penumbra Neurovascular Reperfusion Devices Launched in Europe

May 7, 2024—Penumbra, Inc. announced the CE Mark approval and the launch in Europe of three of its neurovascular reperfusion catheters—Red 43, Red 72 with SendIt technology, and Red 78—for the treatment of acute ischemic stroke.

According to Penumbra, the devices optimize science-based aspiration thrombectomy, or S-BAT, and are engineered with the latest technology in trackability and aspiration to address a wide range of large vessel occlusions.

The Red catheters feature the company’s Redglide technology, which enhances the trackability of the catheters as they navigate the challenging vasculature of the brain; additionally, they have a full-length polytetrafluoroethylene liner designed to maintain their true lumen size under powerful vacuum maximizing aspiration efficiency.

Levansri Makalanda, MBBS, who is Clinical Lead for Neurointervention & Consultant Neuroradiologist at Barts Health NHS Trust, London, United Kingdom, commented on the introduction of the devices in the company’s press release.

“I’m thoroughly impressed with the currently available Red aspiration catheters’ precision in navigating and removing clots,” stated Dr. Makalanda. “I’m eagerly anticipating the Red 43, Red 72 SendIt, and Red 78, which promise to enhance both the reach and efficiency of clot extraction.”